EGFR and pancreatic neoplasm: Finally, Zhang et al. [78] observed that KMP potentiates the sensitivity of pancreatic cancer cells to the epidermal growth factor receptor (EGFR) tyrosine kinase activity inhibitor erlotinib, inhibiting cell proliferation and inducing apoptosis, and, thus, suggested KMP to be a valuable candidate for potentiating the effects of erlotinib.